Protagonist Therapeutics Inc buy BMO Capital Markets
Start price
06.12.24
/
50%
€50.50
Target price
06.12.25
€58.44
Performance (%)
62.38%
End price
07.12.25
€82.00
Summary
This prediction ended on 07.12.25 with a price of €82.00. The BUY prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc saw massive gains of 62.38%. BMO_Capital_Markets has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -1.105% | -1.105% | 105.275% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $62.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€75.50
13.10.25
13.10.25
-
13.10.26
13.10.26
18.54%
01.04.26
01.04.26
Stopped prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
11.03.25
11.03.25
€66.33
11.03.26
11.03.26
66.34%
12.03.26
12.03.26